Results 261 to 270 of about 1,948,626 (333)

BEHAVIOR-GENETIC ANALYSIS OF RESPONSES IN RUNWAY TEST AS MEASURES OF EMOTIONAL REACTIVITY IN RATS: I

, 1975
Osamu Fujita
openalex   +2 more sources

Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers

Molecular Oncology, EarlyView.
This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel, Peyman Zarrineh, Nathnael T. Tuffa, Jigar H. Sheth, Sumitra Mohan, Mudassar Iqbal, Sankari Nagarajan   +6 more
wiley   +1 more source

Practice Recommendations for Genetic Testing of Ataxias. [PDF]

Ann Clin Transl Neurol
Srinivasan SR, Mook AD, Rochman M, Chen JYH, Mu W, Wilmot GR, Rosenthal LS, Uhlmann WR.   +7 more
europepmc   +1 more source

Cross-border genetic testing

Orphanet Journal of Rare Diseases, 2010
Barton David
doaj   +1 more source

Reaping the Full Health Benefits of the Human Genome: The Duty to Warn and The Need to Establish a Comprehensive Federal Regulatory Structure for Genetic Testing

, 2002
Margaret Harrison
openalex   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

Not all information is equally important: informed consent to genetic testing for hereditary cancer. [PDF]

J Cancer Res Clin Oncol
Thomas P, Asmussen S, Klein K, Straub N, Stegen S, Kowalski C, Schüürhuis S, Speiser D, Feufel MA, Kendel F.   +9 more
europepmc   +1 more source

Genetic Testing For Alzheimer’s And Long-Term Care Insurance

, 2010
Donald H. Taylor, Robert Cook‐Deegan, Susan Hiraki, J. Scott Roberts, Dan G. Blazer, Robert C. Green   +5 more
openalex   +2 more sources

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Low Yield of Genetic Testing in Serrated Polyposis Syndrome. [PDF]

Clin Transl Gastroenterol
Upadhye I, Al Maliki H, Cuthill V, Latchford A, Monahan K.   +4 more
europepmc   +1 more source